AGIO
AGIOS PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$34.90
+11.43%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.03x
- Price / sales
- 21.19x
- Price / cash flow
- -5.78x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 15.22x
- EV / EBITDA
- -3.59x
- EV / EBIT
- -3.26x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026